A

Alpha Tau Medical Ltd
NASDAQ:DRTS

Watchlist Manager
Alpha Tau Medical Ltd
NASDAQ:DRTS
Watchlist
Price: 8.54 USD 2.4% Market Closed
Market Cap: $751.6m

Alpha Tau Medical Ltd
Cash & Cash Equivalents

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Alpha Tau Medical Ltd
Cash & Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
A
Alpha Tau Medical Ltd
NASDAQ:DRTS
Cash & Cash Equivalents
$12.2m
CAGR 3-Years
28%
CAGR 5-Years
-5%
CAGR 10-Years
N/A
Nano-X Imaging Ltd
NASDAQ:NNOX
Cash & Cash Equivalents
$49.2m
CAGR 3-Years
8%
CAGR 5-Years
-25%
CAGR 10-Years
N/A
B
Brainsway Ltd
TASE:BWAY
Cash & Cash Equivalents
$70.5m
CAGR 3-Years
13%
CAGR 5-Years
35%
CAGR 10-Years
20%
Inmode Ltd
NASDAQ:INMD
Cash & Cash Equivalents
$471.7m
CAGR 3-Years
40%
CAGR 5-Years
32%
CAGR 10-Years
N/A
Sisram Medical Ltd
HKEX:1696
Cash & Cash Equivalents
$71m
CAGR 3-Years
-5%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
S
Sofwave Medical Ltd
TASE:SOFW
Cash & Cash Equivalents
$34.8m
CAGR 3-Years
3%
CAGR 5-Years
67%
CAGR 10-Years
N/A
No Stocks Found

Alpha Tau Medical Ltd
Glance View

Market Cap
751.6m USD
Industry
Health Care

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company. Company's technology relies on the diffusion of atoms that emit alpha particles within the tumor tissue, and enables alpha radiation to reach the the entire tumor. Precise amounts of radioactive radium-224 affixed that emit short-range alpha radiation enables to damages and kills cancer cells within a short period of time. The firm has one subsidiary Healthcare Capital Corp.

DRTS Intrinsic Value
0.78 USD
Overvaluation 91%
Intrinsic Value
Price $8.54
A

See Also

What is Alpha Tau Medical Ltd's Cash & Cash Equivalents?
Cash & Cash Equivalents
12.2m USD

Based on the financial report for Dec 31, 2025, Alpha Tau Medical Ltd's Cash & Cash Equivalents amounts to 12.2m USD.

What is Alpha Tau Medical Ltd's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 5Y
-5%

Over the last year, the Cash & Cash Equivalents growth was -11%. The average annual Cash & Cash Equivalents growth rates for Alpha Tau Medical Ltd have been 28% over the past three years , -5% over the past five years .

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett